The mitochondrial protease HtrA2 restricts the NLRP3 and AIM2 inflammasomes. by Rodrigue-Gervais, Ian Gaël et al.
Thomas Jefferson University
Jefferson Digital Commons
Department of Biochemistry and Molecular Biology
Faculty Papers Department of Biochemistry and Molecular Biology
5-31-2018
The mitochondrial protease HtrA2 restricts the
NLRP3 and AIM2 inflammasomes.
Ian Gaël Rodrigue-Gervais






Thomas Jefferson University, lindsey.mayes@jefferson.edu
Gabriel André Leiva-Torres
McGill University
See next page for additional authors
Let us know how access to this document benefits you
Follow this and additional works at: https://jdc.jefferson.edu/bmpfp
Part of the Medical Biochemistry Commons, and the Medical Molecular Biology Commons
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
Department of Biochemistry and Molecular Biology Faculty Papers by an authorized administrator of the Jefferson Digital Commons. For more
information, please contact: JeffersonDigitalCommons@jefferson.edu.
Recommended Citation
Rodrigue-Gervais, Ian Gaël; Doiron, Karine; Champagne, Claudia; Mayes, Lindsey; Leiva-Torres,
Gabriel André; Vanié, Paulin; Douglas, Todd; Vidal, Silvia M.; Alnemri, Emad S.; and Saleh, Maya,
"The mitochondrial protease HtrA2 restricts the NLRP3 and AIM2 inflammasomes." (2018).
Department of Biochemistry and Molecular Biology Faculty Papers. Paper 135.
https://jdc.jefferson.edu/bmpfp/135
Authors
Ian Gaël Rodrigue-Gervais, Karine Doiron, Claudia Champagne, Lindsey Mayes, Gabriel André Leiva-Torres,
Paulin Vanié, Todd Douglas, Silvia M. Vidal, Emad S. Alnemri, and Maya Saleh
This article is available at Jefferson Digital Commons: https://jdc.jefferson.edu/bmpfp/135
1ScIeNtIFIc RepoRts |  (2018) 8:8446  | DOI:10.1038/s41598-018-26603-1
www.nature.com/scientificreports
The mitochondrial protease HtrA2 
restricts the NLRP3 and AIM2 
inflammasomes
Ian Gaël Rodrigue-Gervais1,2, Karine Doiron1, Claudia Champagne1, Lindsey Mayes  3,  
Gabriel André Leiva-Torres4, Paulin Vanié Jr2, Todd Douglas5, Silvia M. Vidal4, Emad S. Alnemri3 
& Maya Saleh 1,5,6
Activation of the inflammasome pathway is crucial for effective intracellular host defense. The 
mitochondrial network plays an important role in inflammasome regulation but the mechanisms linking 
mitochondrial homeostasis to attenuation of inflammasome activation are not fully understood. 
Here, we report that the Parkinson’s disease-associated mitochondrial serine protease HtrA2 restricts 
the activation of ASC-dependent NLRP3 and AIM2 inflammasomes, in a protease activity-dependent 
manner. Consistently, disruption of the protease activity of HtrA2 results in exacerbated NLRP3 and 
AIM2 inflammasome responses in macrophages ex vivo and systemically in vivo. Mechanistically, we 
show that the HtrA2 protease activity regulates autophagy and controls the magnitude and duration of 
inflammasome signaling by preventing prolonged accumulation of the inflammasome adaptor ASC. Our 
findings identify HtrA2 as a non-redundant mitochondrial quality control effector that keeps NLRP3 and 
AIM2 inflammasomes in check.
The inflammasomes are central innate immunity effectors that defend the host from infections and a variety 
of intrinsic or environmental insults1. These multi-protein complexes are scaffolded by pattern recognition 
receptors, which upon danger sensing promote the recruitment and activation of caspase-1. The protein ASC 
(apoptosis-associated speck-like protein containing a caspase-recruitment domain) acts as an essential adaptor 
that connects caspase-1 to the sensor in some but not all inflammasomes1. The NOD-like receptor, NLRP3, and 
the interferon-inducible protein AIM2 represent two of the most studied ASC-dependent inflammasome recep-
tors. AIM2 binds to cytosolic DNA, including that of viral origin2,3, and NLRP3 is activated by several danger 
signals1, including viral nucleic acids through the endoribonuclease activity of RNase L4. In parallel to proteo-
lytic maturation of IL-1 family cytokines, caspase-1 cleaves gasdermin D into an amino-terminal pore-forming 
domain that inserts into the cell membrane resulting in IL-1β release and a rapid lytic cell death known as pyrop-
tosis5–7. However, IL-1β release can occur without pyroptosis in some contexts for e.g. following alternative acti-
vation of the inflammasome8. In viral infection, pyroptosis can have a complex effect on infection dynamics and 
host survival. It can eliminate the viral replication niche9, providing fuel for pro-inflammatory and reparative pro-
cesses necessary in the resolution phase10, it can also cause host tissue damage, increasing viral illness severity11–15.
The mitochondrial network, which is central for energy production, metabolism and innate immune sig-
naling, is highly susceptible to physiological and environmental stressors, including viral infections16. Its 
dynamics is maintained by fission and fusion, in tandem with mitophagy, a mitochondria-selective auto-
phagy, and these processes have been linked to inflammasome regulation17,18. Indeed, autophagy is known to 
prevent heightened inflammasome-mediated responses including immunopathology during viral infection12. 
Impaired autophagy, whether at the level of cargo sorting19, autophagosome biogenesis20,21 or the lysosome22, 
translates into defective mitophagy, which results in the selective activation of the NLRP3 inflammasome by 
damaged mitochondria-derived stimuli, including reactive oxygen species (ROS)23. Autophagy can also degrade 
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inflammasome components, including ASC24 and AIM225,26 and has been implicated in the intracellular degrada-
tion of pro-IL-1β27. However, which mitochondrial quality control effectors are required to control the magnitude 
of the inflammasome response have not been clearly defined. A recent study reported that RNA viruses activate 
the mitochondrial fission GTPase dynamin related protein DRP1 to drive mitochondrial damage and activation 
of the NLRP3 inflammasome18, although this has been debated28,29.
Here, we explored the function of the Parkinson’s disease-associated mitochondrial serine protease HtrA2 
in the inflammasome pathway and report that HtrA2 regulates a mitochondrial quality control mechanism 
that selectively inhibits ASC-dependent NLRP3 and AIM2 inflammasomes in an agonist-dependent manner. 
Although initially reported to function in apoptosis30, HtrA2 was later demonstrated as an essential effector of 
mitochondrial protein folding quality control and cell survival30. Its catalytic inactivation in mice and humans 
leads to early-onset fatal infantile neurodegenerative disorder31,32, demonstrating that HtrA2 is neuroprotective. 
Our results show that disruption of the protease activity of HtrA2 (protease loss-of-function) led to impairment 
of autophagy, sustained accumulation of ASC oligomers and heightened NLRP3 and AIM2-mediated inflam-
masome responses. Our results confirm the central role of the mitochondria in integrating viral infection signals 
into regulation of inflammasome signaling33,34, and uncover HtrA2 as a non-redundant effector in this process.
Results
The protease activity of HtrA2 restricts prolonged NLRP3 inflammasome-induced caspase-1 
activity. To address the role of HtrA2 in inflammasome regulation, we first examined inflammasome 
responses in bone marrow-derived macrophages (BMDM) from mice harboring the S276C mnd2 catalytic domain 
mutant allele, which encodes an enzymatically inactive HtrA2 protease31. Because HtrA2 protease deficiency 
leads to neurodegeneration and early postnatal lethality in mice, we also examined BMDMs from viable mnd2tg 
mice, which are deficient in HtrA2 protease activity in all non-neuronal tissues but are rescued from neurological 
disease by HtrA2 transgene expression in neurons35. First, we examined the macrophage NLRP3 inflammasome 
response using different NLRP3 triggers including infection with Sendai paramyxovirus (SeV). Consistent with 
a previous report36, SeV-elicited IL-1β production was impaired in BMDMs from Nlrp3−/− mice or Casp1−/− 
mice harboring a null mutation in Caspase-11 (herein referred to as Casp1/11−/− mice) (Fig. 1a). Deficiency in 
HtrA2 protease activity resulted in increased SeV-elicited IL-1β production (Fig. 1a) and caspase-1-dependent 
cell death (Fig. 1b) in mnd2tg BMDMs relative to protease-sufficient controls. These results were confirmed using 
BMDMs from the original non-transgenic mnd2 mice (Fig. 1c). To confirm regulation of the NLRP3 inflammas-
ome by HtrA2, we examined the response of mnd2 and mnd2tg BMDMs to other NLRP3 stimuli. As for SeV, 
mnd2 BMDMs treated with ATP (Fig. 1d), nigericin (Fig. 1e) or Alum (Fig. 1f) secreted increased amounts of 
IL-1β. Similarly, mnd2tg BMDMs had increased ATP-induced IL-1β maturation and enhanced caspase-1 pro-
teolysis (Fig. 2a) as well as increased caspase-1-dependent cell death (Fig. 1g). In contrast, TNFα production 
in these conditions was comparable among genotypes (Supplementary Fig. 1a). To explore the mechanism by 
which HtrA2 activity impacted the NLRP3 inflammasome, we first examined whether it regulated its priming 
(signal 1) (which requires ERK and NF-κB-dependent upregulation of NLRP3 and pro-IL-1β gene expression37) 
or its activation (signal 2). A previous report showed that, in microglia, HtrA2 cleaved the mitogen-activated 
protein kinase (MAPK) kinase MEK1, which dampened ERK1/2 and NF-κB signaling and inhibited microglial 
activation38. To address if HtrA2 regulated the NLRP3 inflammasome priming step through this or other mecha-
nisms in macrophages, we examined the expression of NLRP3 inflammasome components at steady state or after 
priming with LPS in wild-type, mnd2 or mnd2tg BMDMs. Protein levels of NLRP3, pro-caspase-1, pro-IL-1β 
and ASC were similar in untreated or LPS-primed macrophages from all genotypes (Figs 1h and 2a), indicating 
that HtrA2 is dispensable for NLRP3 inflammasome priming. In contrast, we observed enhanced assembly of the 
NLRP3-ASC complex in mnd2 macrophages as early as 15 minutes after ATP stimulation (Fig. 1i). Similarly, ASC 
oligomerization was not only more potent in mnd2 BMDMs but was also more sustained relative to cells from 
littermate controls (Fig. 1j). Of note, we did not detect HtrA2 in the NLRP3-ASC complex after ATP stimulation 
(Fig. 1i and Supplementary Fig. 1b), suggesting that HtrA2 does not inhibit inflammasome activity by directly 
blocking the NLRP3-ASC interaction. To explore whether the observed increase in NLRP3 inflammasome activa-
tion in the absence of HtrA2 protease activity stemmed from differential production of ROS, a reported regulator 
of the NLRP3 inflammasome23, we quantified ROS levels and found them to be similar between mnd2 and control 
cells (Supplementary Fig. 1c). In sum, these data show that while HtrA2 protease activity is dispensable for the 
expression of core inflammasome components, it is necessary to attenuate NLRP3-ASC activation in response to 
either SeV infection or other stimuli that activate NLRP3 in macrophages.
The HtrA2 protease selectively inhibits NLRP3 and AIM2 inflammasomes. To explore whether 
HtrA2 regulates additional inflammasomes besides NLRP3, BMDMs were transfected with either the dsDNA 
analog polydA:dT or S. typhimurium flagellin to activate the AIM2 or NLRC4 inflammasomes, respectively39. 
Levels of secreted IL-1β and caspase-1 processing were increased in LPS-primed mnd2 and mnd2tg BMDMs 
transfected with dsDNA compared with protease-sufficient BMDMs from littermate control mice (Fig. 2a,b and 
Supplementary Fig. 2a,b). As for the NLRP3 response, mnd2tg BMDMs exhibited increased caspase-1-dependent 
cell death to dsDNA relative to controls (Fig. 2c). In contrast, mnd2tg BMDMs transfected with flagellin showed 
similar levels of active caspase-1, IL-1β production and cell death compared to control BMDMs (Fig. 2a,b,d), 
suggesting that HtrA2 is not involved in modulating the NLRC4 inflammasome. Collectively, these data demon-
strate that HtrA2 inhibits the NLRP3 and AIM2 inflammasome pathways, likely through a common mechanism.
HtrA2 inhibits inflammasome activity indirectly through modulation of autophagy flux. Since 
HtrA2 was reported to control autophagy40, a process implicated in inhibiting both NLRP3 and AIM2 inflammas-
omes17, we interrogated the role of autophagy modulation by HtrA2 in inflammasome inhibition. We expressed 
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the autophagosome marker mCherry-GFP-LC3 in mnd2 and wild-type BMDMs by retrovirus-mediated trans-
duction and used FACS to measure relative levels of autophagic flux after treatment with rapamycin or after 
serum deprivation. Cells with increased flux emit less green fluorescence owing to the acidic environment of the 
autophago-lysosome and this is measured as an increase in the mCherry/GFP ratio41. Wild-type macrophages 
treated with rapamycin showed increased mCherry/GFP ratio indicating that autophagosomes were converting 
into autolysosomes (Fig. 3a,b). This was supported by enhanced phosphatidylethanolamine (PE) conjugation 
of LC3 as detected by changes in LC3-II levels in response to rapamycin (Fig. 3c, lanes 5 versus 1). In con-
trast, mnd2 macrophages showed marginal increase in the mCherry/GFP ratio, suggesting that rapamycin- or 
serum deprivation-induced autophagy flux is greatly attenuated in the absence of functional HtrA2 proteolysis 
(Fig. 3a,b). Consistently, mnd2tg BMDMs showed increased accumulation of LC3-II following rapamcyin com-
pared to controls (Fig. 3c, lane 7 versus 5). As expected, bafilomycin A1 (BafA1), a compound that prevents lyso-
somal degradation, elevated LC3-II levels at steady state (Fig. 3c, lanes 1–4). In contrast, BafA1 did not enhance 
LC3-II accumulation in rapamycin-treated mnd2tg BMDMs (Fig. 3c, lane 8 versus 7), pointing to impaired 
autophagy flux rather than increased autophagy induction in the absence of HtrA2 protease activity. As with 
Figure 1. HtrA2 protease activity inhibits the NLRP3 inflammasome. (a) IL-1β and (b) LDH release 
(cytotoxicity) in supernatants of LPS (500 ng ml−1, 3 h)-primed primary BMDMs (from mnd2tg and protease-
sufficient littermate controls (+/+, +/mnd2tg), and infected with SeV (500 HAU ml−1) for 18 h. (c–f) IL-1β 
secretion by LPS-primed immortalized +/+ and mnd2 macrophages (derived from 3-week-old non-transgenic 
mice) treated with the indicated concentrations of inflammasome agonists: (c) SeV (18 h), (d) ATP (45 min), 
(e) nigericin (30 min), (f) Alum (5 h). (g) LDH release at the indicated times from LPS-primed mnd2tg and 
protease-sufficient littermate (+/+, +/mnd2tg) primary BMDMs treated with ATP (5 mM, 45 min). (h) 
Immunoblot analysis of inflammasome protein levels in lysates from LPS-primed immortalized BMDMs. 
(i) Immunoprecipitation (IP) of endogenous ASC and immunoblot of NLRP3 15 minutes after ATP (5 mM) 
stimulation in IP or cell lysates of LPS-primed immortalized +/+ and mnd2 BMDMs. (j) Immunoblots 
showing ASC oligomerization in disuccinimidyl suberate (DSS) cross-linked NP40-insoluble pellets of primary 
BMDMs, from non-transgenic mnd2 and mnd2/+ littermates (3 weeks old), primed with 500 ng ml−1 LPS for 
the indicated times (min) followed by stimulation with 5 mM ATP for an additional 45 min. Immunoblots of 
cleaved caspase-1 p20 and IL-1β p17 in culture supernatants of the corresponding samples are shown above 
the ASC panel; underneath: total pro-caspase-1 and ASC levels in the cell lysates of all samples. Data are 
representative of two experiments (c-f) mean ± s.d.; n = 3 technical replicates per experiment) and of one 
independent experiment performed once (a: mean ± s.e.m.; b,g: mean ± s.d.; n = 3 mice/genotype, h,i,j). 
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 Tukey one-way ANOVA post-test. (See also Figure S1).
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Figure 2. HtrA2 protease activity inhibits the AIM2 but not NLRC4 inflammasome. (a,b) LPS-primed mnd2tg 
and protease-sufficient littermate (+/+, +/mnd2tg) primary BMDMs were treated with ATP (5 mM, 45 min), 
or transfected with synthetic B-DNA analog (poly dA:dT, 1.8 μg ml−1; 18 h) or flagellin (1 μg ml−1, 18 h). Cell 
supernatants were assayed for (a) cleaved caspase-1 p20 and IL-1βp17 by immunoblot. NLRP3, pro-IL-1β and 
pro-caspase-1 levels were detected in cell lysates by immunoblot. (b) IL-1β levels were quantified by ELISA. 
(c,d) LDH release at the indicated times from LPS-primed mnd2tg and protease-sufficient littermate (+/+, 
+/mnd2tg) primary BMDMs treated with (c) polydA:dT (1.5 μg ml−1) or (d) flagellin (1 μg ml−1). Data are 
representative of two experiments (a,b) (b: mean ±s.e.m.; n = 3 mice per experiment) and of one independent 
experiment performed once (c,d).
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Figure 3. HtrA2 controls autophagy flux-dependent inhibition of the inflammasome. (a) Representative 
differences and (b) quantification of autophagy flux as measured by the flow cytometric ratio of mCherry/GFP 
LC3 in transduced mnd2 and wild-type (+/+) immortalized BMDMs cultured for 16 h in complete media 
(dashed line), serum deprivation (heavy solid line) or rapamycin (5 μM) (solid line). (c) Immunoblot analysis 
for Beclin-1, LC3, IL-1β, caspase-1, cytochrome C and actin from mnd2tg primary BMDMs pre-treated with 
rapamycin (5 μM) for 1.5 h before ATP (5 mM, 2 h) treatment after LPS (0.5 μg ml−1, 4 h) stimulation; +/mnd2tg 
littermates serve as control. (d) Flow cytometry quantification of lysotracker mean fluorescence intensity (MFI) 
from the indicated genotypes. (e-f) IL-1β secretion quantified by ELISA in supernatants from LPS-primed 
mnd2tg BMDMs pre-treated with autophagy inducers rapamycin (3 μM), Z-36 (BCL-XL inhibitor, 3 μM) and 
L-690,330 (IMPase inhibitor, 100 μM) for 1.5 h before (e) ATP (5 mM, 45 min) treatment or (f) poly dA:dT 
transfection (1.5 μg ml−1, 18 h);+/mnd2tg littermates and Casp1/11−/− serve as controls. (g) LDH release and 
(h) ELISA for TNFα in supernatants from BMDMs treated as in e. Data are representative of two experiments 
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rapamycin, ATP stimulation of LPS-primed macrophages induced autophagy in control (Fig. 3c, lane 10 versus 
9) and mnd2tg (Fig. 3c, lane 12 versus 11) BMDMs, with enhanced accumulation of LC3-II in mnd2tg BMDMs 
compared to control cells (Fig. 3c, lane 12 versus 10). Although basal autophagy flux was similar between geno-
types (Fig. 3a,b), confocal imaging revealed that mnd2 macrophages had less GFP-LC3 puncta constitutively and 
fewer cells with greater than 3 strong GFP-LC3 puncta per cell with addition of chloroquine to block lysosomal 
degradation (Supplementary Fig. 3a-c). Combined with reduced basal LC3-II levels (Fig. 3c, lane 3 versus 1), 
these data indicate a decreased autophagosomal content at baseline, as previously reported for HtrA2-deficient 
mouse embryonic fibroblasts (MEFs)40. Furthermore, using the LysoTracker probe, we recorded a ∼50% decrease 
in lysososome abundance in mnd2 macrophages as compared to wild-type cells (Fig. 3d). Our data indicate that 
the need for HtrA2 protease activity in autophagy flux is most apparent under stress conditions, such as inflam-
masome activation, and not under normal growth conditions.
Based on these results, we tested whether increased inflammasome function in mnd2tg BMDMs is due to 
impaired autophagy flux. For that, LPS-primed mnd2tg and protease-sufficient control BMDMs were treated with 
rapamycin shortly prior to ATP stimulation or dsDNA transfection. In agreement with our hypothesis, rapamycin 
not only corrected the exaggerated ATP-induced inflammasome responses of mnd2 macrophages, including IL-1β 
maturation (Fig. 3c,e) and cell death (Fig. 3g), but also reduced IL-1β production in protease-sufficient control 
BMDMs (Supplementary Fig. 3d), in agreement with previous reports24,42. Similarly, rapamycin restored exces-
sive AIM2-induced inflammasome activity to normal levels in mnd2tg BMDMs treated with dsDNA (Fig. 3f), 
indicating that improved autophagy functions reduce the exacerbated response of not only NLRP3 but also AIM2 
inflammasome in HtrA2 protease-deficient cells. We further confirmed this by using L690–330 and Z36, which 
activate autophagy in an mTOR-independent manner, but through distinct mechanisms43,44 (Fig. 3e–f). TNFα 
secretion in supernatants from BMDMs treated with autophagy inducers and ATP was unchanged (Fig. 3h). To 
explore if the role of HtrA2 in autophagy and the turnover of ASC-inflammasome complexes is conserved in 
human cells, we used ASC reporter HEK293T fibroblasts45 and stably depleted by shRNA HtrA2 or the autophagy 
protein ATG5. First, we examined autophagy flux regulation by HtrA2, and found that as for murine mnd2 and 
mnd2tg macrophages, depletion of human HtrA2 similarly resulted in impaired autophagy flux following rapa-
mycin or serum starvation, as assessed using the mCherry-GFP-LC3 reporter (Supplementary Fig. 3e). Second, 
we quantified the accumulation of ASC oligomers using a flow cytometric assay that detects changes of ASC 
distribution within a cell46. As expected, inhibition of autophagic flux using BafA1 increased the content of ASC 
oligomers in response to SeV infection (Supplementary Fig. 3f). Next, we performed cycloheximide-chase anal-
ysis of formed ASC complexes in SeV infected cells. Blocking protein synthesis with cycloheximide at 18 hours 
post-infection revealed slower ASC oligomer turnover in HtrA2- or ATG5-depleted cells than in control cells 
(Supplementary Fig. 3g). Collectively, these data suggest that defects in autophagy flux and lysosomal degradation 
account at least in part for the accumulation of ASC-containing inflammasomes and overactive caspase-1 in cells 
lacking HtrA2.
HtrA2 regulates caspase-1-dependent inflammatory responses in vivo. To determine the role of 
HtrA2 in the regulation of inflammasome responses in vivo, we chose a mouse model of acute MCMV infec-
tion. In this model, caspase-1-dependent IL-18 is produced downstream of AIM2 activation and is important 
for the generation of the early MCMV-induced production of IFNγ by splenic NK cells3. However, in contrast 
to IL-12, IL-18 is dispensable for MCMV viral control and host survival47. Thus, this model is useful to exam-
ine inflammasome responses independently of effects on viral loads. We infected viable mnd2tg mice and lit-
termate controls with 6 × 103 pfu/mouse by intraperitoneal injection. Consistent with previous reports3,48,49, 
infection with MCMV for 40 hours induced IL-18 in the serum (Fig. 4a) and led to MCMV-specific IFNγ pro-
duction by splenic NK cells in wild-type controls, whereas these responses were dampened in Casp1/11−/− mice 
(Fig. 4a,d). In contrast, mnd2tg mice exhibited heightened serum IL-18 levels 40 hours post-infection compared 
to littermate controls, concomitant with larger increases in the frequency of IFNγ-producing splenic NK cells 
(Fig. 4a,b,d). These early inflammasome responses were independent of differences in viral loads, as viral titers 
were equivalent in all genotypes tested (Fig. 4g). Ly49H+ NK1.1+ cells make up to 50% of NK cells in C57BL/6 
mice and are essential in MCMV infection50,51. Whereas mnd2tg mice (C57BL/6 background) displayed com-
parable baseline Ly49H-expressing NK1.1+CD3− frequencies (Fig. 4f) and comparable post-infection spleen 
weights (Supplementary Fig. 4a), they had significantly higher IFNγ-producing Ly49H+ NK cell frequencies 
relative to control littermates (Fig. 4e). This response was specific to MCMV and was not due to NK cell intrinsic 
defects, since PMA and ionomycin stimulation induced comparable numbers of IFNγ+ NK cells regardless of 
the HtrA2 protease functional status (Supplementary Fig. 4b). There was similar expression of the activation 
marker CD69 on NK cells within all genotypes (Fig. 4c, Supplementary Fig. 4c,d), indicating that the observed 
differences could not be attributed to altered numbers of NK cells responding to MCMV. These results indicate 
that under comparable conditions of MCMV infection, mice with HtrA2 loss-of-function develop a stronger 
early caspase-1-dependent inflammatory response in vivo, consistent with HtrA2 being a negative regulator of 
the inflammasome pathway.
(a,b: mean ± s.d., n = 2–3 replicates per experiment; c,e,g,h: mean ±s.e.m., n = 3–4 mice per experiment), 
pooled from two independent experiments (d: mean ± s.em., n = 2 replicates per experiment), and one 
experiment (f; mean ±s.e.m.; n = 3–4 mice). *p < 0.05, ***p < 0.001 (Mann-Withney test (d); Dunnet one-way 
ANOVA post-test (e, f, g)). (See also Figure S3).
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Discussion
Inappropriate inflammasome signaling has been linked to a variety of inflammatory disorders, including viral and 
neurodegenerative diseases14,52–54. Given the evolutionary conservation of the HtrA family of proteases and its 
role in protein metabolism and cell fate55, it is unlikely that HtrA2 functions as a dedicated or direct inhibitor of 
ASC-dependent inflammasomes. In fact, it is not found within the inflammasome complex. Our analysis shows 
that the HtrA2 S276C protease inactive mutant had no effect on LPS-induced pro-inflammatory gene expression 
or inflammasome priming in activated macrophages. Instead, our data suggest that HtrA2 reduces inflammasome 
activity, in part, by promoting the later stages of autophagy during stress conditions, thereby ensuring the turno-
ver of ASC oligomers. We demonstrate with a range of assays, including studies of flux using a mCherry-GFP-LC3 
reporter and lysosome probes and endogenous LC3-II analysis in the presence of the lysosome inhibitor BafA1 
that the protease activity of HtrA2 is necessary for the maturation of autophagosomes into autolysosomes. These 
findings do not exclude the possibility that the defect in autophagy may translate into impaired mitophagy, which 
might explain the overstimulation of NLRP3 in macrophages harboring the HtrA2 protease inactive S276C mnd2 
mutant. However, defects in mitophagy do not account for the observed AIM2 hyperactivation in these cells. 
Furthermore, our results indicate that mnd2 macrophages do not overproduce ROS before or after inflammasome 
stimulation, and do not display increased mitochondrial damage in the conditions tested. This is in contrast to 
phenotypes reported for mitophagy-impaired macrophages19,56, but is in line with studies showing that wild-type 
HtrA2 inhibits mitophagy by cleaving the two mitophagy promoting E3 ligases MUL1 and Parkin57–59. Our obser-
vations that rapamycin and other autophagy inducers corrected the excessive inflammasome activity in HtrA2 
S276C mutant cells suggest that the effect of HtrA2 on inflammasome functions is largely autophagy-dependent. 
The observations that the anti-inflammatory IL-1 family cytokine IL-37 inhibits mTOR, induces autophagy and 
dampens the NLRP3 inflammasome60, further highlights the regulation of the inflammasome pathway by auto-
phagy, and points to a potential therapeutic role of IL-37 in mitochondria-related human immunopathologies.
Figure 4. HtrA2 controls caspase-1-dependent cellular inflammatory responses to MCMV. Mnd2tg, littermate 
controls (+/+, +/mnd2tg) and Casp1/11−/− mice were injected i.p. with MCMV (Smith strain, 6,000 pfu/
mouse) or PBS (mock control, 200 μl/mouse). (a) Serum IL-18 concentrations quantified by ELISA 40 h post-
infection with MCMV or in PBS mock-infected mice. Representative (b) intracellular expression of IFNγ and 
(c) surface expression of CD69, assessed by flow cytometry (gated on NK1.1+CD3−TCRβ− viable splenocytes 
cultured 4 h in medium containing brefeldin A (5 μg ml−1) and monensin (5 μg ml−1) without additional 
stimuli; (x axis, fluorescence intensity; y axis, percentage of maximum); dashed curves indicate NK cells from 
uninfected mice. (d) Quantification of NK-derived IFN-γ responses at 40 h post-infection. (e) Proportions of 
splenic NK cells expressing surface Ly49H and intracellular IFN-γ. (f) Percentages of splenic Ly49H+ NK cells 
prior to infection. (g) MCMV titers in spleen and liver at 40 h post-infection. Symbols indicate individual mice. 
All data represent two independent experiments pooled (mean ± s.e.m., n = 4–8 mice per genotype). *p < 0.05, 
**p < 0.01, ****p < 0.0001 (Tukey (a,d) or Dunnet (e) one-way ANOVA post-test). (See also Figure S4).
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Together, our observations are consistent with emerging data that show that loss of mitochondrial qual-
ity control pathways can disrupt lysosomal proteolytic activity, thus impairing autophagic flux, exacerbating 
inflammatory responses and increasing cell death61,62. Moreover, recent studies support the direct contribution 
of lysosomal homeostasis to the negative regulation of the inflammasome. A similar phenotype of exaggerated 
caspase-1 activity and IL-1β cleavage was reported in human GBA1N370S macrophages, which present lysoso-
mal dysfunction due to deficient glucocerebrosidase activity22. Although autophagy can degrade inflammasome 
components19,24–27, it is also required for IL-1β secretion from living cells through a TRIM16-Sec22b secretory 
autophagic pathway, which is itself modulated by lysosome function63,64. It is tempting to hypothesize that by 
coupling mitochondria-lysosomal crosstalk with inflammasome function, cells can use their metabolic fitness to 
allow flexible adjustment of inflammasome activation.
In vivo, we show that HtrA2 limits IL-18-dependent early inflammatory responses to MCMV (40 hours 
post-infection). A previous study implicated HtrA2 in cytomegalovirus-associated programmed cell death, a 
process occurring late in the infection (day 6–10 post-infection) and antagonized to some extent by the viral pro-
tein vMIA65. It is plausible that during cell death, e.g. at later time points in the infection, HtrA2 exerts functions 
distinct from its physiological role in mitochondrial quality control and autophagy, as previously discussed30.
Our results suggest that HtrA2 regulation of inflammasomes seems to be a conserved mechanism that coun-
teracts inflammation to unrelated viruses downstream of the agonist-induced nucleating step. The independ-
ence of the NLRC4 inflammasome from HtrA2 regulation remains unclear. A plausible reason is that NLRC4 
can recruit and activate pro-caspase-1 independently of ASC66. An alternative reason could be that NLRC4 can 
actively inhibit autophagy67–69. Thus, the overall influence of HtrA2 on inflammasome activation will be depend-
ent on potentially complex interactions between degradative lysosomal pathways, secretory autophagy pathways, 
and on the specific ligands involved. The unexpected role of HtrA2 in modulating autophagy flux to control 
inflammasome responses provides a new framework to understand mitochondria-related immunopathologies in 
humans, including neurodegeneration.
Methods
Mice. All mice were fully on the C57BL/6J background and were bred and maintained at McGill University 
Life Sciences Centre specific pathogen-free animal facility. Nlrp3−/−, Casp1/11−/− (deficient for caspase-1 and 
-11) and C-section re-derived HtrA2mnd2 transgenic mice (referred to here as mnd2tg) have been reported35,70. 
Animals were used when 8–10 weeks old, except for non-transgenic mnd2 mice that were used at 3 weeks of age. 
All animal experiments were in accordance with the regulatory guidelines of the Canadian Council on Animal 
Care and were approved by the McGill University Animal Care and Ethics Committee.
Virus infection and tissue sampling. MCMV (Smith strain) stocks were prepared from salivary glands of 
3-wk old BALB/c mice, aliquoted and stored at −80 °C. Age- and sex-matched mice were infected i.p. with 6 × 103 
pfu/mouse in 200 µl of PBS or mock-infected with PBS alone. Blood for serum isolation (by cardiac puncture), 
spleen and liver were collected from infected mice at 40 hours post-infection for ELISA, viral plaque assays and 
FACS analysis. Spleens were mechanically disrupted and passed through 70 µm cell strainers, following which 1/4 
of the sample was used for plaque assay and the rest was treated with ACK lysis buffer to remove red blood cells. 
The resulting single cell suspensions were used for stimulations and FACS analysis.
Virus titration by plaque forming unit assay. Serial dilutions of spleen and liver homogenates were 
performed in PBS and used to infect confluent MEF cells for 1 hour at 37 °C, 5%CO2. Infection was pursued for 3 
days and plaques were visualized by crystal violet staining.
BMDM culture and stimulation. Femurs and tibias of mnd2tg littermates, mnd2, wild-type, Nlrp3−/− and 
Casp1/11−/− mice were flushed to obtain marrow. Cells were re-suspended at 4 × 106 cells per 10 cm non-tissue 
culture-treated dishes and differentiated into macrophages (BMDM) at 37 °C 5% CO2 for 7 days in RPMI-1640 
medium (containing 10% heat-inactivated FBS, 2 mM glutamine, 100 μg/ml penicillin/streptomycin, 50 μM 
2-mercaptoethanol, 1% non-essential amino acids) supplemented with 25% M-CSF conditioned median on 
days 0, 3 and 5. BMDMs were adhered overnight in 96-well plates (0.75 × 105 cells), in 24-well plates (5 × 105 
cells) or 6-well plates (1 × 106 cells) and primed for 4 hours with 500 ng ml−1 ultra-pure LPS in OPTI-MEM 
(Life Technologies) or otherwise indicated. For inflammasome stimulations, primed cells were infected with 
SeV at 500 HAU ml−1 or treated with 5 mM ATP, 1.8 μg ml−1 dsDNA plus 0.1% v/v Lipofectamine 2000 (Life 
Technologies), 1 μg ml−1 flagellin plus 0.25% v/v DOTAP (Roche), 500 μg ml−1 Alum, 2 μg ml−1 5′pppRNA plus 
0.1% v/v Lipofectamine 2000 for the indicated periods (or otherwise) indicated in figure legends. Cleaved IL-1β 
was measured by ELISA in culture supernatants. Cytotoxicity was measured by LDH release using a CytoTox 96 
Non-Radioactive Cytotoxicity assay (Promega). For pharmacological rescue of autophagy, autophagy inducer 
drugs were added to primed BMDMs 1.3 hours before stimulation with ATP or transfection with dsDNA. 
Immortalized BMDMs were transduced with MMLV-based retrovirus encoding mCherry-EGFP-LC3 and 
selected on day 2 by addition of puromycin (5 μg ml−1).
Confocal microscopy. Immunofluorescence slides were analyzed on an inverted Zeiss LSM510 confo-
cal microscope (20 × 0.75 and 63 × /1.4 Plan-Apochromat or 40 × /1.3 Pan-Neofluar objectives). ImageJ 1.46 
(National Institute of Health) was used for processing of images before cropping to emphasize the main point of 
the image when appropriate; processing was limited to background subtraction, brightness/contrast adjustments 
and pseudo colors addition to facilitate the visualization/interpretation of the results. BMDMs plated on cham-
ber slides overnight were primed with 500 ng ml−1 LPS for 6 h, then stimulated with 5 mM ATP for 15 minutes. 
After stimulations, cells were fixed with 4% formaldehyde for 10 minutes, permeabilized with 0.1% Triton X-100, 
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and the slides were blocked with PBS buffer containing 3% BSA. Cells were immunostained with anti-ASC, 
anti-HtrA2 (V-17, Santa Cruz) and Alexa-Fluor 488 and 647 conjugated secondary antibodies for colocalization 
assay during inflammasome assembly in BMDMs.
Immunoblotting. Cells were homogenized and lysed in B150 buffer (20 mM Tris-HCl pH 8.0, 150 mM KCl, 
10% glycerol, 5 mM MgCl2, 0.1% NP-40 supplemented with a protease inhibitor cocktail (11836153001; Roche), 
followed by boiling in Laemmli sample buffer for examination by immunoblot. For cleavage studies (caspase-1 
p20, and IL-1β p17), 7% of individual culture supernatants was loaded and resolved on gel. For endogenous 
co-immunoprecipitation studies, whole cell lysates (1 mg protein) in B150 were cleared by incubation with pro-
tein G sepharose beads (P3296; Sigma-Aldrich), incubated with anti-ASC antibody for 2.5 hours at 4 °C and pro-
tein G sepharose beads were added for an additional hour. Immunoprecipitates were eluted by boiling in Laemmli 
buffer, electrophoresed on 10% SDS polyacrylamide gels and processed for immunoblot analysis using antibodies 
to mouse anti-NLRP3. ASC polymerization was assayed in disuccinimidyl suberate cross-linked NP-40 insoluble 
pellets following SDS-PAGE fractionation as described before27.
Flow cytometry assays. Measurement of NK responses was performed using a modified version of pub-
lished methods71. Leukocytes isolated from spleen of infected mice were examined for viability by trypan blue 
exclusion (typically ≥95%) and 2 × 105 cells/well was plated in 96-well V bottom plates. Brefeldin A (5 μg ml−1 
final concentration) and monensin (5 μg ml−1) was added for 4 hours at 37 °C. In certain conditions, leukocytes 
were stimulated with PMA (50 ng ml−1) and ionomycin (375 ng ml−1) in the presence of Brefeldin A and mon-
ensin for 4 hours. Following isolation and stimulations, cells were surface stained with the appropriate predeter-
mined concentrations of fluorochrome-labeled antibodies and the amine reactive viability dye Live/Dead fixable 
stain (GhostDye Red780, Tonbo Biosciences) for 20 min in the dark at 4 °C. After intracellular staining for IFNγ, 
cells were fixed in PBS containing 1% formaldehyde and stored at 4 °C in the dark until FACS analysis (performed 
within 12 h). Data were acquired on a Fortessa instrument (BD Biosciences) equipped for the detection of 18 fluo-
rescent parameters including mCherry (yellow laser line 562 nm). Data analysis was performed using FACS DiVa 
version 6.0 software or FlowJo version 10.0. After setting of singlet, lymphocyte gates and exclusion TCRβ+CD3+ 
cells, viable splenic NKs were defined as NK1.1+ cells and analyzed for Ly49H, CD69 and IFNγ expression. 
Autophagy flux was acquired as the ratio of mCherry/GFP and ASC-GFP oligomer formation as GFP-H/GFP-A.
Statistical analysis. Statistical analysis was performed using GraphPad Prism software v5.0. Data are repre-
sented as mean ± standard deviation or standard error of the mean.
References
 1. Broz, P. & Dixit, V. M. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol. 16, 407–420 (2016).
 2. Fernandes-Alnemri, T., Yu, J. W., Datta, P., Wu, J. & Alnemri, E. S. AIM2 activates the inflammasome and cell death in response to 
cytoplasmic DNA. Nature 458, 509–513 (2009).
 3. Rathinam, V. A. et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat 
Immunol. 11, 395–402 (2010).
 4. Chakrabarti, A. et al. RNase L activates the NLRP3 inflammasome during viral infections. Cell Host Microbe 17, 466–477 (2015).
 5. Shi, J. et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526, 660–665 (2015).
 6. Ding, J. et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature 535, 111–116 (2016).
 7. Liu, X. et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535, 153–158 (2016).
 8. Gaidt, M. & Hornung, V. Alternative inflammasome activation enables IL-1β release from living cells. Curr Opin Immunol 44, 7–13 
(2017).
 9. Zhu, S. et al. Nlrp9b inflammasome restricts rotavirus infection in intestinal epithelial cells. Nature 546, 667–670 (2017).
 10. Sagoo, P. et al. In vivo imaging of inflammasome activation reveals a subcapsular macrophage burst response that mobilizes innate 
and adaptive immunity. Nat Med. 22, 64–71 (2016).
 11. Doitsh, G. et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 505, 509–514 (2014).
 12. Lupfer, C. et al. Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus 
infection. Nat Immunol. 14, 480–488 (2013).
 13. Masters, S. L. et al. NLRP1 inflammasome activation induces pyroptosis of hematopoietic progenitor cells. Immunity 37, 1009–1023 
(2012).
 14. Pillai, P. S. et al. Mx1 reveals innate pathways to antiviral resistance and lethal influenza disease. Science 352, 463–466 (2016).
 15. Tate, M. D. et al. Reassessing the role of the NLRP3 inflammasome during pathogenic influenza A virus infection via temporal 
inhibition. Sci Rep. 6, 27912 (2016).
 16. Khan, M., Syed, G. H., Kim, S. J. & Siddiqui, A. Mitochondrial dynamics and viral infections: A close nexus. Biochim Biophys Acta. 
1853, 2822–2833 (2015).
 17. Harris, J. et al. Autophagy and inflammasomes. Mol Immunol. 86, 10–15 (2017).
 18. Wang, X. et al. RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway. Nat 
Immunol 15, 1126–1133 (2014).
 19. Zhong, Z. et al. NF-kappaB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria. Cell 164, 896–910 
(2016).
 20. Nakahira, K. et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated 
by the NALP3 inflammasome. Nat Immunol. 12, 222–230 (2011).
 21. Saitoh, T. et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 456, 264–268 
(2008).
 22. Aflaki, E. et al. Lysosomal storage and impaired autophagy lead to inflammasome activation in Gaucher macrophages. Aging Cell 15, 
77–88 (2016).
 23. Zhou, R., Yazdi, A. S., Menu, P. & Tschopp, J. A role for mitochondria in NLRP3 inflammasome activation. Nature 469, 221–225 
(2011).
 24. Shi, C. S. et al. Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated 
inflammasomes for destruction. Nat Immunol. 13, 255–263 (2012).
www.nature.com/scientificreports/
1 0ScIeNtIFIc RepoRts |  (2018) 8:8446  | DOI:10.1038/s41598-018-26603-1
 25. Liu, T. et al. TRIM11 Suppresses AIM2 Inflammasome by Degrading AIM2 via p62-Dependent Selective Autophagy. Cell Rep. 16, 
1988–2002 (2016).
 26. Kimura, T. et al. TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity. J Cell Biol. 210, 973–989 
(2015).
 27. Harris, J. et al. Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation. J Biol Chem. 286, 9587–9597 
(2011).
 28. Kang, S. et al. Caspase-8 scaffolding function and MLKL regulate NLRP3 inflammasome activation downstream of TLR3. Nat 
Commun 6, 7515 (2015).
 29. Park, S. et al. Defective mitochondrial fission augments NLRP3 inflammasome activation. Sci Rep. 5, 15489 (2015).
 30. Vande Walle, L., Lamkanfi, M. & Vandenabeele, P. The mitochondrial serine protease HtrA2/Omi: an overview. Cell Death Differ. 15, 
453–460 (2008).
 31. Jones, J. M. et al. Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature 425, 
721–727 (2003).
 32. Strauss, K. M. et al. Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson’s disease. Hum Mol Genet. 14, 
2099–2111 (2005).
 33. Monlun, M., Hyernard, C., Blanco, P., Lartigue, L. & Faustin, B. Mitochondria as Molecular Platforms Integrating Multiple Innate 
Immune Signalings. J Mol Biol 429, 1–13 (2017).
 34. Mills, E. L., Kelly, B. & O’Neill, L. A. J. Mitochondria are the powerhouses of immunity. Nat Immunol. 18, 488–498 (2017).
 35. Kang, S. et al. Loss of HtrA2/Omi activity in non-neuronal tissues of adult mice causes premature aging. Cell Death Differ. 20, 
259–269 (2013).
 36. Park, S. et al. The mitochondrial antiviral protein MAVS associates with NLRP3 and regulates its inflammasome activity. J Immunol. 
191, 4358–4366 (2013).
 37. Ghonime, M. G. et al. Inflammasome priming by lipopolysaccharide is dependent upon ERK signaling and proteasome function. J 
Immunol. 192, 3881–3888 (2014).
 38. Hu, Q. et al. The protease Omi cleaves the mitogen-activated protein kinase kinase MEK1 to inhibit microglial activation. Sci Signal. 
5, ra61 (2012).
 39. Zhao, Y. et al. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 477, 596–600 
(2011).
 40. Li, B. et al. Omi/HtrA2 is a positive regulator of autophagy that facilitates the degradation of mutant proteins involved in 
neurodegenerative diseases. Cell Death Differ. 17, 1773–1784 (2010).
 41. Gump, J. M. et al. Autophagy variation within a cell population determines cell fate through selective degradation of Fap-1. Nat Cell 
Biol. 16, 47–54 (2014).
 42. Moon, J. S. et al. mTORC1-Induced HK1-Dependent Glycolysis Regulates NLRP3 Inflammasome Activation. Cell Rep. 12, 102–115 
(2015).
 43. Lin, J. et al. A novel Bcl-XL inhibitor Z36 that induces autophagic cell death in Hela cells. Autophagy 5, 314–320 (2009).
 44. Sarkar, S. et al. Lithium induces autophagy by inhibiting inositol monophosphatase. The J Cell Biol. 170, 1101–1111 (2005).
 45. Fernandes-Alnemri, T. et al. The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via 
caspase-1 activation. Cell Death Differ. 14, 1590–1604 (2007).
 46. Sester, D. P. et al. A novel flow cytometric method to assess inflammasome formation. J Immunol. 194, 455–462 (2015).
 47. Pien, G. C., Satoskar, A. R., Takeda, K., Akira, S. & Biron, C. A. Cutting edge: selective IL-18 requirements for induction of 
compartmental IFN-gamma responses during viral infection. J Immunol. 165, 4787–4791 (2000).
 48. Daniels, K. A. et al. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody 
to Ly49H. J Exp Med. 194, 29–44 (2001).
 49. Khare, S. et al. The PYRIN domain-only protein POP3 inhibits ALR inflammasomes and regulates responses to infection with DNA 
viruses. Nat Immunol. 15, 343–353 (2014).
 50. Lee, S. H. et al. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the 
C-type lectin superfamily. Nat Genet. 28, 42–45 (2001).
 51. Brown, M. G. et al. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292, 934–937 
(2001).
 52. Doitsh, G. & Greene, W. C. Dissecting How CD4 T Cells Are Lost During HIV Infection. Cell Host Microbe 19, 280–291 (2016).
 53. Heneka, M. T. et al. NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice. Nature 493, 674–678 
(2013).
 54. Yan, Y. et al. Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell 160, 62–73 (2015).
 55. Clausen, T., Southan, C. & Ehrmann, M. The HtrA family of proteases: implications for protein composition and cell fate. Mol Cell 
10, 443–455 (2002).
 56. Ip, W. K. E., Hoshi, N., Shouval, D. S., Snapper, S. & Medzhitov, R. Anti-inflammatory effect of IL-10 mediated by metabolic 
reprogramming of macrophages. Science 356, 513–519 (2017).
 57. Park, H. M. et al. The serine protease HtrA2/Omi cleaves Parkin and irreversibly inactivates its E3 ubiquitin ligase activity. Biochem 
Biophys Res Commun. 387, 537–542 (2009).
 58. Cilenti, L. et al. Inactivation of Omi/HtrA2 protease leads to the deregulation of mitochondrial Mulan E3 ubiquitin ligase and 
increased mitophagy. Biochimica et biophysica acta 1843, 1295–1307 (2014).
 59. Rojansky, R., Cha, M. Y. & Chan, D. C. Elimination of paternal mitochondria in mouse embryos occurs through autophagic 
degradation dependent on PARKIN and MUL1. eLife 5 (2016).
 60. Dinarello, C. A. et al. Suppression of innate inflammation and immunity by interleukin family member interleukin-37. Eur J 
Immunol 46, 1067–1081 (2016).
 61. Demers-Lamarche, J. et al. Loss of Mitochondrial Function Impairs Lysosomes. J Biol Chem. 291, 10263–10276 (2016).
 62. Baixauli, F. et al. Mitochondrial Respiration Controls Lysosomal Function during Inflammatory T Cell Responses. Cell Metab. 22, 
485–498 (2015).
 63. Kimura, T. et al. Dedicated SNAREs and specialized TRIM cargo receptors mediate secretory autophagy. EMBO J. 36, 42–60 (2017).
 64. Zhang, M., Kenny, S. J., Ge, L., Xu, K. & Schekman, R. Translocation of interleukin-1beta into a vesicle intermediate in autophagy-
mediated secretion. eLife 4, pii: e11205 (2015).
 65. McCormick, A. L., Roback, L. & Mocarski, E. S. HtrA2/Omi terminates cytomegalovirus infection and is controlled by the viral 
mitochondrial inhibitor of apoptosis (vMIA). PLoS Pathog. 4, e1000063 (2008).
 66. Zhang, L. et al. Cryo-EM structure of the activated NAIP2-NLRC4 inflammasome reveals nucleated polymerization. Science 350, 
404–409 (2015).
 67. Suzuki, T. et al. Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected 
macrophages. Plos Pathog. 3, e111 (2007).
 68. Jabir, M. S. et al. Caspase-1 cleavage of the TLR adaptor TRIF inhibits autophagy and beta-interferon production during 
Pseudomonas aeruginosa infection. Cell Host Microbe 15, 214–227 (2014).
 69. Jounai, N. et al. NLRP4 negatively regulates autophagic processes through an association with beclin1. J Immunol. 186, 1646–1655 
(2011).
www.nature.com/scientificreports/
1 1ScIeNtIFIc RepoRts |  (2018) 8:8446  | DOI:10.1038/s41598-018-26603-1
 70. Rodrigue-Gervais, I. G. et al. Cellular inhibitor of apoptosis protein cIAP2 protects against pulmonary tissue necrosis during 
influenza virus infection to promote host survival. Cell Host Microbe 15, 23–35 (2014).
 71. Dupaul-Chicoine, J. et al. The Nlrp3 Inflammasome Suppresses Colorectal Cancer Metastatic Growth in the Liver by Promoting 
Natural Killer Cell Tumoricidal Activity. Immunity 43, 751–763 (2015).
Acknowledgements
We thank V. Dixit and Genentech for providing anti-caspase-1 p20 clone 4B4 and Nlrp3−/− mice; R. Flavell for 
Casp1/11−/− mice; and the McGill University Life Sciences Complex Advanced Bioimaging Facility. Supported by 
the Canadian Institutes for Health Research (M.S. 2016-362740; fellowship and research allowance for I.G.R.G.; 
S.M.V.); the Burroughs Wellcome Fund (to M.S.); Fonds de Recherche en Santé du Québec (Senior Investigator 
award to M.S.; fellowship to I.G.R.G.); Natural Sciences and Engineering Research Council of Canada (2016-
243176 to M.S. and 2017-06568 to I.G.R.G.) and NIH (AR055398 to E.A).
Author Contributions
I.G.R.G. and M.S. conceived the study, designed the research and wrote the paper I.G.R.G., K.D., C.C., L.M. 
P.V. and T.D. performed experiments and analyzed data G.A.L.T. performed MCMV infections; S.M.V. provided 
MCMV virus and helped interpret experiments E.A. provided reagents, the HtrA2mnd2 transgenic mice and 
helped interpret experiments. All authors discussed the results and commented on the manuscript.
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-018-26603-1.
Competing Interests: The authors declare no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2018
